Caredx, Inc. splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Services at $274.5 million, 72% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
497
|
380
|
334
|
280
|
322
|
296
|
192
|
127
|
77
|
48
|
41
|
| Services |
389
+49.6%
share 78.2%
|
274
+10.1%
share 72.3%
|
249
+18.9%
share 74.7%
|
210
-20.5%
share 74.8%
|
264
+1.7%
share 82.0%
|
259
+58.5%
share 87.5%
|
164
+56.5%
share 85.1%
|
105
+73.4%
share 82.3%
|
60
+82.1%
share 78.8%
|
33
share 68.5%
|
—
|
| Patient And Digital Solutions |
72
+39.8%
share 14.5%
|
57
+30.5%
share 15.0%
|
44
+17.5%
share 13.1%
|
37
+28.9%
share 13.2%
|
29
+180.1%
share 8.9%
|
10
+10.8%
share 3.5%
|
9
+119.0%
share 4.8%
|
4
+612.4%
share 3.3%
|
1
+1.9%
share 0.8%
|
1
share 1.2%
|
—
|
| Product |
36
-21.7%
share 7.3%
|
48
+18.6%
share 12.7%
|
41
+21.7%
share 12.2%
|
34
+14.6%
share 12.0%
|
29
+9.0%
share 9.1%
|
27
+39.0%
share 9.1%
|
19
+5.6%
share 10.0%
|
18
+16.6%
share 14.4%
|
16
+7.1%
share 20.5%
|
15
share 30.3%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- CDNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1217234
- Former names
- XDx, Inc. (until Nov 15, 2011); EXPRESSION DIAGNOSTICS INC (until Dec 14, 2005)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.